alcedaplin   Click here for help

GtoPdb Ligand ID: 14682

Synonyms: compound 352 [WO2023141432] | MXE-829 | MXE829 | MZE829
Compound class: Synthetic organic
Comment: Alcedaplin (MXE829) is an apolipoprotein L1 (APOL1) inhibitor/modulator that is proposed to treat APOL1-associated nephropathy, particularly in individuals with a high-risk APOL1 genotype [1]. It is designed to inhibit both APOL1 pore formation and channel function.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 77.4
Molecular weight 548.99
XLogP 3.13
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@]1(C[C@@H](C1)N2C=NC3=C2C(=CC(=C3)OCCN4CCC5(CC4)C6=CC(=CC=C6NC5=O)Cl)C(F)(F)F)O
Isomeric SMILES C=1C(OCCN2CCC3(C=4C=C(Cl)C=CC4NC3=O)CC2)=CC=5N=CN([C@@H]6C[C@](C)(O)C6)C5C1C(F)(F)F
InChI InChI=1S/C27H28ClF3N4O3/c1-25(37)13-17(14-25)35-15-32-22-12-18(11-20(23(22)35)27(29,30)31)38-9-8-34-6-4-26(5-7-34)19-10-16(28)2-3-21(19)33-24(26)36/h2-3,10-12,15,17,37H,4-9,13-14H2,1H3,(H,33,36)/t17-,25+
InChI Key SFKXAXOEKZVXDA-CKQQTVSASA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
MZE829/MXE829 was progressed as a clinical candidate.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT06830629 A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease Phase 2 Interventional Maze Therapeutics